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 Name Type q Name Type q 
C19 CG321 -0.1810 C23 CG2O1 0.3970 
C20 CG321 -0.1950 H9 HGA1 0.0900 
H27 HGA2 0.0900 O1 OG2D1 -0.4900 
H42 HGA2 0.0900 N4 NG2S1 -0.3950 
H43 HGA2 0.0900 C24 CG2R61 0.1390 
C21 CG324 0.1750 H10 HGP1 0.3180 
N3 NG3P2 -0.3840 C27 CG2R61 -0.1210 
H29 HGA2 0.0900 C29 CG2R61 -0.1090 
H44 HGA2 0.0900 H13 HGR61 0.1150 
H30 HGP2 0.3200 H15 HGR61 0.1150 
H45 HGP2 0.3200 C28 CG2R61 -0.1150 
C22 CG314 0.3580 C26 CG2R61 -0.1090 
H14 HGR61 0.1150 C16 CG321 -0.1800 
Name Type q Name Type q 
H12 HGR61 0.1150 C15 CG321 -0.1820 
C25 CG2R61 -0.1210 H24 HGA2 0.0900 
H11 HGR61 0.1150 H39 HGA2 0.0900 
C30 CG321 -0.1770 H38 HGA2 0.0900 
C31 CG2O5 0.3370 H23 HGA2 0.0900 
H46 HGA2 0.0900 C14 CG321 -0.1680 
H31 HGA2 0.0900 N2 NG311 -0.4150 
O2 OG2D3 -0.4700 H37 HGA2 0.0900 
C32 CG2R61 0.1220 H22 HGA2 0.0900 
C37 CG2R61 -0.1170 H8 HGPAM1 0.3380 
H17 HGR61 0.1150 C5 CG2R61 0.0780 
C33 CG2R61 -0.0010 C3 CG2R61 -0.0030 
C34 CG331 -0.2690 C2 CG2R61 0.3720 
H32 HGA3 0.0900 N1 NG2R60 -0.6580 
H47 HGA3 0.0900 C9 CG2R61 0.2980 
H3 HGA3 0.0900 C13 CG321 -0.1770 
C38 CG2R61 -0.1160 H36 HGA2 0.0900 
H18 HGR61 0.1150 H21 HGA2 0.0900 
C36 CG331 -0.2690 C12 CG321 -0.1840 
H33 HGA3 0.0900 C10 CG321 -0.1840 
H49 HGA3 0.0900 H20 HGA2 0.0900 
H48 HGA3 0.0900 H35 HGA2 0.0900 
C18 CG321 -0.1810 H34 HGA2 0.0900 
C17 CG321 -0.1800 H19 HGA2 0.0900 
H26 HGA2 0.0900 C6 CG321 -0.1750 
H41 HGA2 0.0900 C7 CG2R61 -0.0210 
H25 HGA2 0.0900 H2 HGA2 0.0900 
H40 HGA2 0.0900 H1 HGA2 0.0900 
C11 CG2R61 -0.1130 C1 CG2R61 -0.1190 
H4 HGR61 0.1150 C8 CG2R61 -0.1160 
H7 HGR61 0.1150 C4 CG2R61 -0.1110 
H6 HGR61 0.1150 H5 HGR61 0.1150 
Figure S1. Atom types and partial atomic charges for compound 10 obtained from CHARMM General 











C NMR spectra for 8-10 
 
 
Figure S2. The 
1
H NMR spectrum of 8. 
 
Figure S3. The 
13
C NMR spectrum of 8. 
 
 
Figure S4. The 
1
H NMR spectrum of 9. 
 Figure S5. The 
13





H NMR spectrum of 10. 
 
 
Figure S7. The 
13
C NMR spectrum of 10. 
 
 
 Figure S8. The gyration radius of the whole AChE during the 100 ns MD simulation. 
 
Figure S9. The RMSD of protein's backbone during the 100 ns MD simulation. The first frame was taken 
as a reference. 
 
